Detalles de la búsqueda
1.
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial.
Lancet;
2024 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38824941
2.
Radiomics-based nomogram guides adaptive de-intensification in locoregionally advanced nasopharyngeal carcinoma following induction chemotherapy.
Eur Radiol;
2024 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38514481
3.
Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial.
Lancet Oncol;
23(4): 479-490, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35240053
4.
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial.
Lancet;
398(10297): 303-313, 2021 07 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34111416
5.
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma.
N Engl J Med;
381(12): 1124-1135, 2019 09 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31150573
6.
Association of delayed chemoradiotherapy with elevated Epstein-Barr virus DNA load and adverse clinical outcome in nasopharyngeal carcinoma treatment during the COVID-19 pandemic: a retrospective study.
Cancer Cell Int;
22(1): 331, 2022 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36316696
7.
Causal relationship between genetically predicted depression and cancer risk: a two-sample bi-directional mendelian randomization.
BMC Cancer;
22(1): 353, 2022 Mar 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35361153
8.
Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma: A Randomized Clinical Trial.
JAMA;
328(8): 728-736, 2022 08 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35997729
9.
Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses.
Mol Cancer;
20(1): 14, 2021 01 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33430876
10.
Evolving landscape and academic attitudes toward the controversies of global immuno-oncology trials.
Int J Cancer;
149(1): 108-118, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33544890
11.
Liquid biopsy posttreatment surveillance in endemic nasopharyngeal carcinoma: a cost-effective strategy to integrate circulating cell-free Epstein-Barr virus DNA.
BMC Med;
19(1): 193, 2021 08 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34433440
12.
Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events.
BMC Cancer;
21(1): 860, 2021 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34315423
13.
Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa.
Eur Radiol;
30(2): 816-822, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31650266
14.
Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial.
Int J Cancer;
145(1): 295-305, 2019 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30613964
15.
Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
Cancer;
125(1): 79-89, 2019 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30351466
16.
Evidence Underlying Recommendations and Payments from Industry to Authors of the National Comprehensive Cancer Network Guidelines.
Oncologist;
24(4): 498-504, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30459237
17.
Pan-cancer genomic analyses reveal prognostic and immunogenic features of the tumor melatonergic microenvironment across 14 solid cancer types.
J Pineal Res;
66(3): e12557, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30638277
18.
Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.
Lancet Oncol;
19(3): 382-393, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29428165
19.
Anti-epidermal growth factor receptor therapy concurrently with induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
Cancer Sci;
109(5): 1609-1616, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29575438
20.
Prognostic value of nutritional risk screening 2002 scale in nasopharyngeal carcinoma: A large-scale cohort study.
Cancer Sci;
109(6): 1909-1919, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29624824